- Home
- DCTH vs MCS Comparison
DCTH vs MCS Comparison
Compare DCTH & MCS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DCTH
- MCS
- Stock Information
- Founded
- DCTH 1988
- MCS 1935
- Country
- DCTH United States
- MCS United States
- Employees
- DCTH N/A
- MCS N/A
- Industry
- DCTH Medical/Dental Instruments
- MCS Movies/Entertainment
- Sector
- DCTH Health Care
- MCS Consumer Discretionary
- Exchange
- DCTH Nasdaq
- MCS Nasdaq
- Market Cap
- DCTH 518.0M
- MCS 549.0M
- IPO Year
- DCTH N/A
- MCS N/A
- Fundamental
- Price
- DCTH $11.01
- MCS $15.27
- Analyst Decision
- DCTH Strong Buy
- MCS Strong Buy
- Analyst Count
- DCTH 4
- MCS 3
- Target Price
- DCTH $22.75
- MCS $24.00
- AVG Volume (30 Days)
- DCTH 491.4K
- MCS 222.0K
- Earning Date
- DCTH 05-13-2025
- MCS 05-01-2025
- Dividend Yield
- DCTH N/A
- MCS 1.83%
- EPS Growth
- DCTH N/A
- MCS N/A
- EPS
- DCTH N/A
- MCS N/A
- Revenue
- DCTH $37,205,000.00
- MCS $695,086,000.00
- Revenue This Year
- DCTH $128.78
- MCS $11.76
- Revenue Next Year
- DCTH $54.07
- MCS $4.64
- P/E Ratio
- DCTH N/A
- MCS N/A
- Revenue Growth
- DCTH 1701.69
- MCS 0.42
- 52 Week Low
- DCTH $4.26
- MCS $9.56
- 52 Week High
- DCTH $16.97
- MCS $23.16
- Technical
- Relative Strength Index (RSI)
- DCTH 31.21
- MCS 29.15
- Support Level
- DCTH $12.18
- MCS $16.38
- Resistance Level
- DCTH $13.39
- MCS $17.07
- Average True Range (ATR)
- DCTH 0.85
- MCS 0.50
- MACD
- DCTH -0.16
- MCS 0.00
- Stochastic Oscillator
- DCTH 10.34
- MCS 9.79
Stock Price Comparison Chart: DCTH vs MCS
About DCTH Delcath Systems Inc.
Delcath Systems Inc is an oncology company. It is focused on the treatment of primary and metastatic liver cancers. The firm's product, Melphalan Hydrochloride for Injection along with the Delcath Hepatic Delivery System, or Melphalan/HDS, is a drug and device combination product, designed to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects.
About MCS Marcus Corporation (The)
Marcus Corp is engaged in two business segments, which are Theatres and Hotels and Resorts. The Theatre segment operates multiscreen motion picture theatres in Wisconsin, Illinois, Iowa, Minnesota, Missouri, Nebraska, North Dakota, Ohio ands others, a family entertainment center in Wisconsin and a retail center in Missouri; Hotels and Resorts segment owns and operates full-service hotels and resorts in Wisconsin, Illinois, and Nebraska and manages full-service hotels, resorts and other properties in Wisconsin, Minnesota, Texas, Nevada, California, and North Carolina. It generates maximum revenue from the Theatres segment.